Know what changed. Skip what didn’t.
Pheasycian filters out repetition and publication noise, so you see the developments that genuinely deserve your attention.
Please read and accept before accessing Pheasycian content.
Pheasycian provides AI-assisted summaries and syntheses of medical literature, primarily for healthcare professionals, for educational and informational purposes only. Pheasycian does not provide medical advice, clinical instructions, diagnoses, treatments, prescriptions, or recommendations to adopt, discontinue, or modify any medical practice.
Pheasycian uses AI-assisted monitoring to identify and retrieve information from publicly available sources, including medical literature and other publicly accessible scientific information. Pheasycian’s policy is not to access, retrieve, use, or disclose private article access credentials, confidential materials, identifiable patient information, private medical records, or other non-public patient or clinical data.
Where Content is identified as Physician Verified, a Pheasycian physician administrator has personally reviewed the relevant source articles and prepared, reviewed, or validated the synthesis presented on the Pheasycian website. Pheasycian physician administrators do not copy and paste sentences, paragraphs, tables, graphs, figures, or other substantive content from source publications into Pheasycian summaries. Pheasycian syntheses are independently written in the physician administrator’s own words based on their review and interpretation of the cited source material. Source publications are identified and cited so that readers can consult the original material directly. Physician verification does not replace the reader’s independent review of the underlying evidence and does not constitute medical advice or a recommendation regarding patient care.
Pheasycian Content is intentionally concise and is designed to help healthcare professionals efficiently identify and understand relevant medical information. Because summaries necessarily omit details, each physician or other healthcare professional must independently review the original evidence, current clinical guidelines, official prescribing or product information, institutional protocols, applicable laws and regulations, and the circumstances of the individual patient before making any clinical decision or changing medical practice.
All clinical decisions, treatment decisions, and changes in medical practice remain solely the responsibility of the treating healthcare professional. To the fullest extent permitted by applicable law, Pheasycian assumes no responsibility or liability for any decision, action, omission, practice change, treatment choice, or patient outcome based wholly or partly on Pheasycian Content.
All Pheasycian-original summaries, syntheses, wording, and website content are protected by applicable copyright laws and may not be reproduced or distributed without prior authorization, except as permitted by law.
By selecting “Agree and continue,” you confirm that you have read and accepted this Disclaimer and the Content Use Terms.
Practice-changing evidence. Clinical meaning. Five minutes.
Your medical evidence website, verified in English, French, and Arabic. Skip the article overload. Read the findings most likely to change practice and assess their clinical application in practice.
Subscribers receive specialty-specific emails whenever Pheasycian publishes a Flash Alert, an official action, a newly verified or updated article, or a complete edition. Only items related to their selected specialties are included.
Know what changed. Skip what didn’t.
Pheasycian filters out repetition and publication noise, so you see the developments that genuinely deserve your attention.
Your time is part of what we protect.
We do not publish simply to fill a schedule. When there is no meaningful update, we protect your time by sending nothing.
Connected evidence across every edition.
See beyond your specialty. Four findings to carry forward: major clinical benefits, important safety signals and the cautions that matter.
Initial intermittent dialysis did not establish noninferiority to continuous therapy and was associated with higher 90-day mortality (63.1% versus 53.5%). The trial stopped early, so the size of the mortality difference requires caution and the findings concern the initial treatment strategy.
Original article ↗Adding tarlatamab to durvalumab after initial disease control increased median survival from the start of maintenance to 21.1 months versus 12.7 months. Cytokine release syndrome was common, and the interim findings do not determine the best treatment sequence or apply to patients whose cancer progressed during initial therapy.
Original article ↗For selected patients with salvageable brain tissue presenting 24–72 hours after stroke, thrombectomy improved the distribution of functional outcomes at 90 days. Intracranial hemorrhage and mortality were higher, making the balance between recovery and harm central to interpretation.
Original article ↗In patients with atrioventricular block, preserved ventricular function and substantial anticipated pacing, left bundle-branch area pacing reduced the combined clinical endpoint to 2.4% versus 12.5%. The trial did not establish a separate mortality benefit, and its lead-specific technique and selected population matter when applying the findings.
Original article ↗Choose your specialty alerts, or take a look at updates from other specialties.
Clinical guidelines from published Pheasycian editions.
Free participation and physician credit. Check time, credits and registration before opening the provider’s activity.
Explore medical events worldwide: conferences, workshops, seminars, webinars, symposia, and courses. Find event dates, abstract submission deadlines, and official registration links.
The number beside each country shows how many events match your filters. A country with (0) has no matching events.
Select one or two specialties, or choose three or more for All Access. Emails contain only relevant Flash Alerts, official actions, verified updates, and editions.
More access. More time for medicine. Pheasycian is extending free access as we introduce weekly updates—giving more physicians the opportunity to make concise, physician-verified evidence part of their routine.